PACB (PACB)
Quantitative Summary
DeterministicBelow-average fundamentals indicated by Piotroski score of 3/9; Altman Z of -6.1 falls in the academic distress zone.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of PACB reveal severe distress, characterized by a negative ROIC-WACC spread of -69.6%, indicating that capital allocation is actively destroying value relative to the cost of equity. This deterioration stems from an inability to generate bottom-line returns, evidenced by net margins collapsing to -341.5% despite maintaining gross margins at 28.6%. The DuPont decomposition implicitly highlights a failure in profitability rather than leverage or turnover issues driving returns. Compounding this fundamental weakness are alarming risk metrics: the Altman Z-Score of -6.1 signals an extremely high probability of bankruptcy, while the Piotroski F-Score of 3/9 confirms significant financial deterioration compared to industry peers. Furthermore, the Beneish M-Score of -5.22 suggests aggressive earnings management or potential accounting irregularities that further erode investor confidence in reported figures.
Valuation analysis is rendered difficult by these negative fundamentals, as traditional multiples lack context when net income is deeply negative and revenue growth remains modest at 3.9% year-over-year. The market appears to be pricing in substantial risk rather than sustainable value creation, given the disconnect between top-line expansion and catastrophic bottom-line erosion. Without a clear path to positive cash flows or margin recovery, any implied growth rate derived from standard DCF models would likely result in negative fair values, suggesting the current price may already reflect extreme pessimism regarding future solvency. The absence of sector data prevents a normalized multiple comparison, but the internal metrics suggest the stock is trading on speculation rather than earnings power.
Risk-adjusted performance indicators underscore the speculative nature of this equity. The annualized Fama-French Alpha of -8.16% indicates that the stock has underperformed its risk-adjusted benchmark significantly over time. Additionally, factor tilts reveal a pronounced exposure to growth risks with an HML score of -0.865 and severe weakness in profitability factors at RMW of -1.296. These data points collectively paint a picture of high volatility driven by fundamental instability rather than disciplined capital allocation or operational efficiency improvements.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like ARKG or ARKK, the fund manager is mechanically forced to buy or sell PACB shares regardless of PACB's individual fundamentals. We estimate $32M of passive capital is structurally linked to PACB through 3 tracked ETFs. Passive flows have a limited but growing influence on PACB's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 3 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in PACB to visualize passive redemption contagion across ETFs and collateral stocks.
If PACB (PACB) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CRISPR THERAPEUTICS AG (CRSP) as the most exposed collateral stock, sharing 2 ETFs with PACB. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 3 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
PACB Ownership Dynamics
Passive funds hold 1 in every 12 PACB shares, reducing daily market volatility.
PACB (PACB) exerts measurable gravity on the passive index market, currently representing 1.1% of the ARK Genomic Revolution ETF (ARKG) and 0.3% of the ARK Innovation ETF (ARKK). Across 3 tracked ETFs, approximately 25M shares (8.1% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest PACB Exposure
Float lock-up computed from 3 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
PACB Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for PACB over the past year sits near $1.27 (14% of 252-day volume). The current price of $1.58 trades 24.4% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (14% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-11 | 29,175 | $1.41 | $41,136.75 |
| 2026-05-08 | 7,592 | $1.65 | $12,526.8 |
| 2026-05-07 | 180 | $1.71 | $307.8 |
| 2026-05-04 | 172 | $1.60 | $275.2 |
| 2026-04-23 | 201 | $1.71 | $343.71 |
| 2026-04-21 | 1,162 | $1.74 | $2,021.88 |
| 2026-04-16 | 127 | $1.60 | $203.2 |
| 2026-04-15 | 9,814 | $1.57 | $15,407.98 |
| 2026-04-14 | 7,237 | $1.45 | $10,493.65 |
| 2026-04-13 | 564 | $1.34 | $755.76 |
| 2026-04-02 | 12,732 | $1.35 | $17,188.2 |
| 2026-04-01 | 55,443 | $1.32 | $73,184.76 |
| 2026-03-31 | 20,030 | $1.26 | $25,237.8 |
| 2026-03-30 | 13,229 | $1.26 | $16,668.54 |
| 2026-03-26 | 24,205 | $1.39 | $33,644.95 |
| 2026-03-25 | 4,185 | $1.39 | $5,817.15 |
| 2026-03-24 | 2,489 | $1.39 | $3,459.71 |
| 2026-03-20 | 399 | $1.40 | $558.6 |
| 2026-03-19 | 85,523 | $1.33 | $113,745.59 |
| 2026-03-13 | 1,418 | $1.27 | $1,800.86 |
| 2026-03-12 | 53,641 | $1.35 | $72,415.35 |
| 2026-03-10 | 61,450 | $1.39 | $85,415.5 |
| 2026-03-06 | 27,078 | $1.52 | $41,158.56 |
| 2026-03-04 | 45,907 | $1.52 | $69,778.64 |
| 2026-02-27 | 7,200 | $1.78 | $12,816 |
| 2026-02-19 | 150,860 | $1.63 | $245,901.8 |
| 2026-02-13 | 207,250 | $1.84 | $381,340 |
| 2026-02-12 | 30 | $1.84 | $55.2 |
| 2026-02-05 | 7,405 | $1.95 | $14,439.75 |
| 2026-02-04 | 634,395 | $2.04 | $1.3M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| BFLY | 0.515 | 0.638 | Moderate |
| TXG | 0.500 | 0.525 | Moderate |
| PSNL | 0.491 | 0.554 | Moderate |
| ILMN | 0.474 | 0.497 | Moderate |
| RXRX | 0.452 | 0.570 | Moderate |
| BEAM | 0.430 | 0.470 | Moderate |
| NTRA | 0.408 | 0.509 | Moderate |
| ADPT | 0.399 | 0.561 | Moderate |
| ABSI | 0.394 | 0.454 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare PACB to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.